EyeReply ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.8% 11.4% 6.2% 7.9% 5.1%  
Credit score (0-100)  41 21 37 30 42  
Credit rating  BBB BB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,867 1,469 1,361 1,212 1,541  
EBITDA  480 -114 62.3 88.6 353  
EBIT  466 -125 44.8 70.8 336  
Pre-tax profit (PTP)  448.7 -145.3 41.4 49.2 327.6  
Net earnings  343.6 -114.4 55.1 7.0 250.0  
Pre-tax profit without non-rec. items  449 -145 41.4 49.2 328  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  20.2 8.7 44.4 26.6 8.9  
Shareholders equity total  394 79.2 134 141 391  
Interest-bearing liabilities  0.0 0.0 100 0.3 0.0  
Balance sheet total (assets)  1,162 1,102 935 644 1,069  

Net Debt  -452 -271 -535 -506 -359  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,867 1,469 1,361 1,212 1,541  
Gross profit growth  0.0% -21.3% -7.4% -10.9% 27.1%  
Employees  2 2 3 3 3  
Employee growth %  0.0% 0.0% 50.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,162 1,102 935 644 1,069  
Balance sheet change%  0.0% -5.2% -15.1% -31.1% 66.0%  
Added value  480.0 -113.6 62.3 88.4 353.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  6 -23 18 -36 -36  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  24.9% -8.5% 3.3% 5.8% 21.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  40.1% -11.1% 4.4% 9.0% 39.2%  
ROI %  118.3% -53.0% 28.6% 37.7% 126.0%  
ROE %  87.3% -48.4% 51.6% 5.1% 93.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  33.9% 7.2% 14.4% 21.9% 36.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -94.2% 238.3% -857.8% -570.8% -101.6%  
Gearing %  0.0% 0.0% 74.5% 0.2% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.8% 43.1% 4,733.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.5 1.1 1.1 1.2 1.5  
Current Ratio  1.5 1.1 1.1 1.2 1.5  
Cash and cash equivalent  452.4 270.8 634.8 506.1 359.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  373.4 94.9 70.8 93.9 361.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  240 -57 21 29 118  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  240 -57 21 30 118  
EBIT / employee  233 -63 15 24 112  
Net earnings / employee  172 -57 18 2 83